| Maryland | 000-32191 | 52-2264646 | ||||||
| (State of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
||||||
| (Address of principal executive offices) | (Zip Code) | ||||
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
| Common Stock, par value $0.20 | TROW |
The NASDAQ Stock Market LLC
(Nasdaq Global Select Market)
|
||||||||||||
| Three months ended | Year ended | ||||||||||||||||||||||||||||||||||||||||||||||
| (in millions, except per-share data) | 12/31/2024 | 12/31/2023 | Change(1) |
9/30/2024 | Change(1) |
12/31/2024 |
12/31/2023 | Change(1) |
|||||||||||||||||||||||||||||||||||||||
| U.S. GAAP basis | |||||||||||||||||||||||||||||||||||||||||||||||
| Investment advisory fees | $ | 1,667.2 | $ | 1,435.9 | 16.1 | % | $ | 1,627.3 | 2.5 | % | $ | 6,399.7 | $ | 5,709.5 | 12.1 | % | |||||||||||||||||||||||||||||||
Performance-based advisory fees(2) |
$ | 19.3 | $ | 25.3 | (23.7) | % | $ | 5.6 | n/m | $ | 59.3 | $ | 38.2 | 55.2 | % | ||||||||||||||||||||||||||||||||
Capital allocation-based income(3) |
$ | (5.2) | $ | 40.2 | n/m | $ | 4.6 | n/m | $ | 46.6 | $ | 161.9 | (71.2) | % | |||||||||||||||||||||||||||||||||
| Net revenues | $ | 1,824.5 | $ | 1,642.0 | 11.1 | % | $ | 1,785.6 | 2.2 | % | $ | 7,093.6 | $ | 6,460.5 | 9.8 | % | |||||||||||||||||||||||||||||||
| Operating expenses | $ | 1,256.1 | $ | 1,254.8 | 0.1 | % | $ | 1,172.0 | 7.2 | % | $ | 4,760.3 | $ | 4,474.3 | 6.4 | % | |||||||||||||||||||||||||||||||
| Net operating income | $ | 568.4 | $ | 387.2 | 46.8 | % | $ | 613.6 | (7.4) | % | $ | 2,333.3 | $ | 1,986.2 | 17.5 | % | |||||||||||||||||||||||||||||||
| Non-operating income (loss) | $ | 4.6 | $ | 259.7 | n/m | $ | 212.5 | n/m | $ | 486.3 | $ | 504.1 | (3.5) | % | |||||||||||||||||||||||||||||||||
| Net income - T. Rowe Price Group, Inc. | $ | 439.9 | $ | 437.6 | 0.5 | % | $ | 603.0 | (27.0) | % | $ | 2,100.1 | $ | 1,788.7 | 17.4 | % | |||||||||||||||||||||||||||||||
| Diluted earnings per common share | $ | 1.92 | $ | 1.90 | 1.1 | % | $ | 2.64 | (27.3) | % | $ | 9.15 | $ | 7.76 | 17.9 | % | |||||||||||||||||||||||||||||||
Adjusted basis(4) |
|||||||||||||||||||||||||||||||||||||||||||||||
| Operating expenses | $ | 1,222.6 | $ | 1,150.7 | 6.2 | % | $ | 1,099.0 | 11.2 | % | $ | 4,498.8 | $ | 4,260.7 | 5.6 | % | |||||||||||||||||||||||||||||||
| Operating expenses, excluding accrued carried interest related compensation | $ | 1,218.7 | $ | 1,135.5 | 7.3 | % | $ | 1,087.4 | 12.1 | % | $ | 4,456.3 | $ | 4,190.7 | 6.3 | % | |||||||||||||||||||||||||||||||
| Net operating income | $ | 620.2 | $ | 502.7 | 23.4 | % | $ | 718.4 | (13.7) | % | $ | 2,685.9 | $ | 2,263.2 | 18.7 | % | |||||||||||||||||||||||||||||||
| Non-operating income (loss) | $ | 34.3 | $ | 49.5 | (30.7) | % | $ | 51.2 | (33.0) | % | $ | 148.7 | $ | 140.8 | 5.6 | % | |||||||||||||||||||||||||||||||
| Net income - T. Rowe Price Group, Inc. | $ | 484.8 | $ | 394.7 | 22.8 | % | $ | 586.5 | (17.3) | % | $ | 2,139.5 | $ | 1,750.1 | 22.3 | % | |||||||||||||||||||||||||||||||
| Diluted earnings per common share | $ | 2.12 | $ | 1.72 | 23.3 | % | $ | 2.57 | (17.5) | % | $ | 9.33 | $ | 7.59 | 22.9 | % | |||||||||||||||||||||||||||||||
Assets under management (in billions) |
|||||||||||||||||||||||||||||||||||||||||||||||
| Average assets under management | $ | 1,638.6 | $ | 1,374.3 | 19.2 | % | $ | 1,589.5 | 3.1 | % | $ | 1,561.9 | $ | 1,362.3 | 14.7 | % | |||||||||||||||||||||||||||||||
| Ending assets under management | $ | 1,606.6 | $ | 1,444.5 | 11.2 | % | $ | 1,630.9 | (1.5) | % | $ | 1,606.6 | $ | 1,444.5 | 11.2 | % | |||||||||||||||||||||||||||||||
Investment advisory annualized effective fee rate (EFR) (in bps) |
|||||||||||||||||||||||||||||||||||||||||||||||
| EFR without performance-based fees | 40.5 | 41.5 | (1.0) | 40.7 | (0.2) | 41.0 | 41.9 | (0.9) | |||||||||||||||||||||||||||||||||||||||
| EFR with performance-based fees | 40.9 | 42.2 | (1.3) | 40.9 | — | 41.4 | 42.2 | (0.8) | |||||||||||||||||||||||||||||||||||||||
Three months ended 12/31/2024 |
|||||||||||||||||||||||||||||
| (in billions) | Equity | Fixed income, including money market | Multi-asset(1) |
Alternatives(2) |
Total | ||||||||||||||||||||||||
| Assets under management at beginning of period | $ | 832.0 | $ | 186.3 | $ | 560.9 | $ | 51.7 | $ | 1,630.9 | |||||||||||||||||||
| Net cash flows prior to manager-driven distributions | (8.2) | 3.5 | (15.5) | 1.7 | (18.5) | ||||||||||||||||||||||||
| Manager-driven distributions | — | — | — | (0.8) | (0.8) | ||||||||||||||||||||||||
| Net cash flows | (8.2) | 3.5 | (15.5) | 0.9 | (19.3) | ||||||||||||||||||||||||
Net market appreciation (depreciation) and income(3) |
5.9 | (1.7) | (9.4) | 0.2 | (5.0) | ||||||||||||||||||||||||
| Change during the period | (2.3) | 1.8 | (24.9) | 1.1 | (24.3) | ||||||||||||||||||||||||
Assets under management at December 31, 2024 |
$ | 829.7 | $ | 188.1 | $ | 536.0 | $ | 52.8 | $ | 1,606.6 | |||||||||||||||||||
| Three months ended | |||||||||||||||||||||||||||||
| (in millions) | 12/31/2024 | 12/31/2023 | Change | 9/30/2024 | Change | ||||||||||||||||||||||||
| Investment advisory fees | |||||||||||||||||||||||||||||
| Equity | $ | 1,006.2 | $ | 864.3 | 16.4 | % | $ | 978.5 | 2.8 | % | |||||||||||||||||||
| Fixed income, including money market | 106.2 | 98.2 | 8.1 | % | 104.1 | 2.0 | % | ||||||||||||||||||||||
| Multi-asset | 473.8 | 400.6 | 18.3 | % | 465.8 | 1.7 | % | ||||||||||||||||||||||
| Alternatives | 81.0 | 72.8 | 11.3 | % | 78.9 | 2.7 | % | ||||||||||||||||||||||
| Total investment advisory fees | 1,667.2 | 1,435.9 | 16.1 | % | 1,627.3 | 2.5 | % | ||||||||||||||||||||||
Performance-based advisory fees(1) |
19.3 | 25.3 | n/m | 5.6 | n/m | ||||||||||||||||||||||||
Capital allocation-based income(2) |
(5.2) | 40.2 | n/m | 4.6 | n/m | ||||||||||||||||||||||||
| Administrative, distribution, and servicing fees | 143.2 | 140.6 | 1.8 | % | 148.1 | (3.3) | % | ||||||||||||||||||||||
| Net revenues | $ | 1,824.5 | $ | 1,642.0 | 11.1 | % | $ | 1,785.6 | 2.2 | % | |||||||||||||||||||
| Average AUM (in billions): | |||||||||||||||||||||||||||||
| Equity | $ | 842.7 | $ | 704.9 | 19.5 | % | $ | 813.1 | 3.6 | % | |||||||||||||||||||
| Fixed income, including money market | 186.9 | 168.4 | 11.0 | % | 183.3 | 2.0 | % | ||||||||||||||||||||||
| Multi-asset | 556.3 | 453.6 | 22.6 | % | 542.3 | 2.6 | % | ||||||||||||||||||||||
| Alternatives | 52.7 | 47.4 | 11.2 | % | 50.8 | 3.7 | % | ||||||||||||||||||||||
| Average AUM | $ | 1,638.6 | $ | 1,374.3 | 19.2 | % | $ | 1,589.5 | 3.1 | % | |||||||||||||||||||
| Investment advisory annualized effective fee rate (bps) | 40.5 | 41.5 | (1.0) | 40.7 | (0.2) | ||||||||||||||||||||||||
| Investment advisory annualized effective fee rate, including performance-based fees (bps) | 40.9 | 42.2 | (1.3) | 40.9 | — | ||||||||||||||||||||||||
| Three months ended | |||||||||||||||||||||||||||||
| (in millions) | 12/31/2024 | 12/31/2023 | Change (1) |
9/30/2024 | Change (1) |
||||||||||||||||||||||||
| Compensation, benefits, and related costs | $ | 705.4 | $ | 649.4 | 8.6 | % | $ | 632.9 | 11.5 | % | |||||||||||||||||||
| Acquisition-related retention agreements | 14.2 | 13.5 | 5.2 | % | 4.0 | 255.0 | % | ||||||||||||||||||||||
Capital allocation-based income compensation(2) |
(3.4) | 10.6 | n/m | (2.0) | n/m | ||||||||||||||||||||||||
| Market-related change in deferred compensation liability | (6.7) | 61.9 | n/m | 43.4 | n/m | ||||||||||||||||||||||||
| Total compensation and related costs | 709.5 | 735.4 | (3.5) | % | 678.3 | 4.6 | % | ||||||||||||||||||||||
| Distribution and servicing | 92.9 | 75.7 | 22.7 | % | 91.6 | 1.4 | % | ||||||||||||||||||||||
| Advertising and promotion | 50.2 | 44.4 | 13.1 | % | 20.8 | 141.3 | % | ||||||||||||||||||||||
| Product and recordkeeping related costs | 74.5 | 68.1 | 9.4 | % | 75.0 | (0.7) | % | ||||||||||||||||||||||
| Technology, occupancy, and facility costs | 169.3 | 171.6 | (1.3) | % | 164.0 | 3.2 | % | ||||||||||||||||||||||
| General, administrative, and other | 128.3 | 128.1 | 0.2 | % | 104.2 | 23.1 | % | ||||||||||||||||||||||
| Change in fair value of contingent consideration | — | (9.6) | n/m | (13.4) | n/m | ||||||||||||||||||||||||
| Acquisition-related amortization and impairment costs | 31.4 | 41.1 | (23.6) | % | 51.5 | (39.0) | % | ||||||||||||||||||||||
| Total operating expenses | $ | 1,256.1 | $ | 1,254.8 | 0.1 | % | $ | 1,172.0 | 7.2 | % | |||||||||||||||||||
Total adjusted operating expenses(3) |
$ | 1,222.6 | $ | 1,150.7 | 6.2 | % | $ | 1,099.0 | 11.2 | % | |||||||||||||||||||
| (in millions) | Three months ended | ||||||||||||||||
| 12/31/2024 | 12/31/2023 | 9/30/2024 | |||||||||||||||
| Net gains (losses) from non-consolidated T. Rowe Price investment products | |||||||||||||||||
| Cash and discretionary investments | |||||||||||||||||
| Dividend income | $ | 39.8 | $ | 33.1 | $ | 37.4 | |||||||||||
| Market-related gains (losses) and equity in earnings (losses) | (1.4) | 5.4 | 5.9 | ||||||||||||||
| Total net gains (losses) from cash and discretionary investments | 38.4 | 38.5 | 43.3 | ||||||||||||||
| Seed capital investments | |||||||||||||||||
| Dividend income | 1.6 | 0.6 | 0.5 | ||||||||||||||
| Market-related gains (losses) and equity in earnings (losses) | 1.9 | 25.3 | 21.3 | ||||||||||||||
| Net gains (losses) recognized upon deconsolidation | 0.2 | (0.7) | (0.6) | ||||||||||||||
| Investments used to hedge deferred compensation liabilities | (9.2) | 65.0 | 41.1 | ||||||||||||||
| Total net gains (losses) from non-consolidated T. Rowe Price investment products | 32.9 | 128.7 | 105.6 | ||||||||||||||
| Other investment income (loss) | 11.8 | 12.8 | 13.4 | ||||||||||||||
| Net gains (losses) on investments | 44.7 | 141.5 | 119.0 | ||||||||||||||
| Net gains (losses) on consolidated investment products | (36.4) | 119.2 | 85.9 | ||||||||||||||
| Other gains (losses), including foreign currency gains (losses) | (3.7) | (1.0) | 7.6 | ||||||||||||||
| Non-operating income (loss) | $ | 4.6 | $ | 259.7 | $ | 212.5 | |||||||||||
Adjusted non-operating income (loss)(1) |
$ | 34.3 | $ | 49.5 | $ | 51.2 | |||||||||||
| Year ended | |||||||||||
| 12/31/2024 | 12/31/2023 | ||||||||||
| Statutory U.S. federal income tax rate | 21.0 | % | 21.0 | % | |||||||
State income taxes for current year, net of federal income tax benefits(1) |
2.9 | 2.3 | |||||||||
Net (income) losses attributable to redeemable non-controlling interests(2) |
(0.3) | (0.5) | |||||||||
| Net excess tax losses (benefits) from stock-based compensation plans activity | (0.2) | 0.1 | |||||||||
| Valuation allowances | 0.2 | 3.4 | |||||||||
| Other items | 0.7 | — | |||||||||
| Effective income tax rate | 24.3 | % | 26.3 | % | |||||||
| Public Relations | Investor Relations | ||||||||||
| Jamaal Mobley | Linsley Carruth | ||||||||||
| 410-345-3403 | 410-345-3717 | ||||||||||
| jamaal.mobley@troweprice.com | linsley.carruth@troweprice.com | ||||||||||
| Unaudited Consolidated Statements of Income | |||||||||||||||||||||||||||||||||||
| (in millions, except per-share amounts) | |||||||||||||||||||||||||||||||||||
| Three months ended | Year ended | ||||||||||||||||||||||||||||||||||
| Revenues | 12/31/2024 | 12/31/2023 | 9/30/2024 | 12/31/2024 | 12/31/2023 | ||||||||||||||||||||||||||||||
| Investment advisory fees | $ | 1,667.2 | $ | 1,435.9 | $ | 1,627.3 | $ | 6,399.7 | $ | 5,709.5 | |||||||||||||||||||||||||
Performance-based advisory fees(1) |
19.3 | 25.3 | 5.6 | 59.3 | 38.2 | ||||||||||||||||||||||||||||||
| Capital allocation-based income | (5.2) | 40.2 | 4.6 | 46.6 | 161.9 | ||||||||||||||||||||||||||||||
| Administrative, distribution, and servicing fees | 143.2 | 140.6 | 148.1 | 588.0 | 550.9 | ||||||||||||||||||||||||||||||
| Net revenues | 1,824.5 | 1,642.0 | 1,785.6 | 7,093.6 | 6,460.5 | ||||||||||||||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||||||||||||||
| Compensation, benefits, and related costs | 705.4 | 649.4 | 632.9 | 2,603.4 | 2,450.7 | ||||||||||||||||||||||||||||||
| Acquisition-related retention agreements | 14.2 | 13.5 | 4.0 | 44.8 | 55.0 | ||||||||||||||||||||||||||||||
| Capital allocation-based income compensation | (3.4) | 10.6 | (2.0) | 5.4 | 44.6 | ||||||||||||||||||||||||||||||
| Market-related change in deferred compensation liabilities | (6.7) | 61.9 | 43.4 | 104.3 | 123.2 | ||||||||||||||||||||||||||||||
| Total compensation and related costs | 709.5 | 735.4 | 678.3 | 2,757.9 | 2,673.5 | ||||||||||||||||||||||||||||||
| Distribution and servicing | 92.9 | 75.7 | 91.6 | 354.1 | 289.9 | ||||||||||||||||||||||||||||||
| Advertising and promotion | 50.2 | 44.4 | 20.8 | 129.6 | 114.2 | ||||||||||||||||||||||||||||||
| Product and recordkeeping related costs | 74.5 | 68.1 | 75.0 | 297.5 | 291.0 | ||||||||||||||||||||||||||||||
| Technology, occupancy, and facility costs | 169.3 | 171.6 | 164.0 | 644.1 | 632.6 | ||||||||||||||||||||||||||||||
| General, administrative, and other | 128.3 | 128.1 | 104.2 | 433.8 | 421.3 | ||||||||||||||||||||||||||||||
| Change in fair value of contingent consideration | — | (9.6) | (13.4) | (13.4) | (82.4) | ||||||||||||||||||||||||||||||
| Acquisition-related amortization and impairment costs | 31.4 | 41.1 | 51.5 | 156.7 | 134.2 | ||||||||||||||||||||||||||||||
| Total operating expenses | 1,256.1 | 1,254.8 | 1,172.0 | 4,760.3 | 4,474.3 | ||||||||||||||||||||||||||||||
| Net operating income | 568.4 | 387.2 | 613.6 | 2,333.3 | 1,986.2 | ||||||||||||||||||||||||||||||
| Non-operating income (loss) | |||||||||||||||||||||||||||||||||||
| Net gains (losses) on investments | 44.7 | 141.5 | 119.0 | 363.2 | 355.2 | ||||||||||||||||||||||||||||||
| Net gains (losses) on consolidated investment products | (36.4) | 119.2 | 85.9 | 130.3 | 164.6 | ||||||||||||||||||||||||||||||
| Other gains (losses), including foreign currency gains (losses) | (3.7) | (1.0) | 7.6 | (7.2) | (15.7) | ||||||||||||||||||||||||||||||
| Total non-operating income (loss) | 4.6 | 259.7 | 212.5 | 486.3 | 504.1 | ||||||||||||||||||||||||||||||
| Income before income taxes | 573.0 | 646.9 | 826.1 | 2,819.6 | 2,490.3 | ||||||||||||||||||||||||||||||
| Provision for income taxes | 156.3 | 173.3 | 185.7 | 683.8 | 654.6 | ||||||||||||||||||||||||||||||
| Net income | 416.7 | 473.6 | 640.4 | 2,135.8 | 1,835.7 | ||||||||||||||||||||||||||||||
| Less: net income (loss) attributable to redeemable non-controlling interests | (23.2) | 36.0 | 37.4 | 35.7 | 47.0 | ||||||||||||||||||||||||||||||
| Net income attributable to T. Rowe Price Group, Inc. | 439.9 | 437.6 | 603.0 | 2,100.1 | 1,788.7 | ||||||||||||||||||||||||||||||
| Less: net income allocated to outstanding restricted stock and stock unit holders | 11.6 | 11.7 | 15.5 | 55.8 | 44.4 | ||||||||||||||||||||||||||||||
| Net income allocated to T. Rowe Price common stockholders | $ | 428.3 | $ | 425.9 | $ | 587.5 | $ | 2,044.3 | $ | 1,744.3 | |||||||||||||||||||||||||
| Earnings per share | |||||||||||||||||||||||||||||||||||
| Basic | $ | 1.93 | $ | 1.91 | $ | 2.64 | $ | 9.18 | $ | 7.78 | |||||||||||||||||||||||||
| Diluted | $ | 1.92 | $ | 1.90 | $ | 2.64 | $ | 9.15 | $ | 7.76 | |||||||||||||||||||||||||
| Weighted-average common shares | |||||||||||||||||||||||||||||||||||
| Outstanding | 222.4 | 223.5 | 222.3 | 222.8 | 224.1 | ||||||||||||||||||||||||||||||
| Outstanding assuming dilution | 222.8 | 224.0 | 222.8 | 223.3 | 224.8 | ||||||||||||||||||||||||||||||
Summary of Adjusted Basis(2) |
Three months ended | Year ended | |||||||||||||||||||||||||||||||||
| (in millions, except per-share data) | 12/31/2024 | 12/31/2023 | 9/30/2024 | 12/31/2024 | 12/31/2023 | ||||||||||||||||||||||||||||||
| Operating expenses | $ | 1,222.6 | $ | 1,150.7 | $ | 1,099.0 | $ | 4,498.8 | $ | 4,260.7 | |||||||||||||||||||||||||
| Operating expenses, excluding accrued carried interest related compensation | $ | 1,218.7 | $ | 1,135.5 | $ | 1,087.4 | $ | 4,456.3 | $ | 4,190.7 | |||||||||||||||||||||||||
| Net operating income | $ | 620.2 | $ | 502.7 | $ | 718.4 | $ | 2,685.9 | $ | 2,263.2 | |||||||||||||||||||||||||
| Non-operating income (loss) | $ | 34.3 | $ | 49.5 | $ | 51.2 | $ | 148.7 | $ | 140.8 | |||||||||||||||||||||||||
| Net income attributable to T. Rowe Price | $ | 484.8 | $ | 394.7 | $ | 586.5 | $ | 2,139.5 | $ | 1,750.1 | |||||||||||||||||||||||||
| Diluted earnings per common share | $ | 2.12 | $ | 1.72 | $ | 2.57 | $ | 9.33 | $ | 7.59 | |||||||||||||||||||||||||
| Assets Under Management | Year ended 12/31/2024 |
||||||||||||||||||||||||||||
| (in billions) | Equity | Fixed income, including money market | Multi-asset(1) |
Alternatives(2) |
Total | ||||||||||||||||||||||||
| Assets under management at beginning of period | $ | 743.6 | $ | 170.0 | $ | 483.0 | $ | 47.9 | $ | 1,444.5 | |||||||||||||||||||
| Net cash flows prior to manager-driven distributions | (52.0) | 12.6 | (6.5) | 6.4 | (39.5) | ||||||||||||||||||||||||
| Manager-driven distributions | — | — | — | (3.7) | (3.7) | ||||||||||||||||||||||||
| Net cash flows | (52.0) | 12.6 | (6.5) | 2.7 | (43.2) | ||||||||||||||||||||||||
Net market appreciation and gains(3) |
138.1 | 5.5 | 59.5 | 2.2 | 205.3 | ||||||||||||||||||||||||
| Change during the period | 86.1 | 18.1 | 53.0 | 4.9 | 162.1 | ||||||||||||||||||||||||
Assets under management at December 31, 2024 |
$ | 829.7 | $ | 188.1 | $ | 536.0 | $ | 52.8 | $ | 1,606.6 | |||||||||||||||||||
| Net Revenues | Year ended | ||||||||||||||||
| (in millions) | 12/31/2024 | 12/31/2023 | % Change | ||||||||||||||
| Investment advisory fees | |||||||||||||||||
| Equity | $ | 3,864.7 | $ | 3,442.3 | 12.3 | % | |||||||||||
| Fixed income, including money market | 410.7 | 400.4 | 2.6 | % | |||||||||||||
| Multi-asset | 1,814.1 | 1,583.4 | 14.6 | % | |||||||||||||
| Alternatives | 310.2 | 283.4 | 9.5 | % | |||||||||||||
| Total investment advisory fees | $ | 6,399.7 | $ | 5,709.5 | 12.1 | % | |||||||||||
| Average AUM (in billions): | |||||||||||||||||
| Equity | $ | 804.3 | $ | 705.2 | 14.1 | % | |||||||||||
| Fixed income, including money market | 178.6 | 169.3 | 5.5 | % | |||||||||||||
| Multi-asset | 529.0 | 442.3 | 19.6 | % | |||||||||||||
| Alternatives | 50.0 | 45.5 | 9.9 | % | |||||||||||||
| Average AUM | $ | 1,561.9 | $ | 1,362.3 | 14.7 | % | |||||||||||
| Non-Operating Income (Loss) | Year ended | ||||||||||
| (in millions) | 12/31/2024 | 12/31/2023 | |||||||||
| Net gains (losses) from non-consolidated T. Rowe Price investment products | |||||||||||
| Cash and discretionary investments | |||||||||||
| Dividend income | $ | 138.6 | $ | 109.1 | |||||||
| Market-related gains (losses) and equity in earnings (losses) | 4.8 | 24.5 | |||||||||
| Total net gains (losses) from cash and discretionary investments | 143.4 | 133.6 | |||||||||
| Seed capital investments | |||||||||||
| Dividend income | 2.4 | 1.8 | |||||||||
| Market-related gains (losses) and equity in earnings (losses) | 62.0 | 50.3 | |||||||||
| Net gains (losses) recognized upon deconsolidation | (0.4) | — | |||||||||
| Investments used to hedge deferred compensation liabilities | 96.4 | 123.6 | |||||||||
| Total net gains (losses) from non-consolidated T. Rowe Price investment products | 303.8 | 309.3 | |||||||||
| Other investment income (loss) | 59.4 | 45.9 | |||||||||
| Net gains (losses) on investments | 363.2 | 355.2 | |||||||||
| Net gains (losses) on consolidated investment portfolios | 130.3 | 164.6 | |||||||||
| Other gains (losses), including foreign currency gains (losses) | (7.2) | (15.7) | |||||||||
| Non-operating income (loss) | $ | 486.3 | $ | 504.1 | |||||||
Adjusted non-operating income (loss)(1) |
$ | 148.7 | $ | 140.8 | |||||||
| Year ended | |||||||||||||||||||||||
| 12/31/2024 | |||||||||||||||||||||||
(in millions) |
Cash flow attributable to T. Rowe Price | Cash flow attributable to consolidated investment products | Elims |
As reported |
|||||||||||||||||||
| Cash flows from operating activities | |||||||||||||||||||||||
| Net income (loss) | $ | 2,100.1 | $ | 120.5 | $ | (84.8) | $ | 2,135.8 | |||||||||||||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities | |||||||||||||||||||||||
| Depreciation, amortization and impairments of property, equipment and software | 254.1 | — | — | 254.1 | |||||||||||||||||||
| Amortization and impairment of acquisition-related assets and retention agreements | 250.1 | — | — | 250.1 | |||||||||||||||||||
| Fair value remeasurement of contingent liability | (13.4) | — | — | (13.4) | |||||||||||||||||||
| Stock-based compensation expense | 247.3 | — | — | 247.3 | |||||||||||||||||||
| Net (gains) losses recognized on investments | (425.0) | — | 84.8 | (340.2) | |||||||||||||||||||
| Net investments in investment products used to economically hedge deferred compensation liabilities | (123.2) | — | 30.0 | (93.2) | |||||||||||||||||||
| Net change in trading securities held by consolidated investment products | — | (760.4) | — | (760.4) | |||||||||||||||||||
| Other changes | 23.9 | 6.1 | (24.5) | 5.5 | |||||||||||||||||||
| Net cash provided by (used in) operating activities | 2,313.9 | (633.8) | 5.5 | 1,685.6 | |||||||||||||||||||
| Net cash provided by (used in) investing activities | (187.9) | (15.8) | 26.2 | (177.5) | |||||||||||||||||||
| Net cash provided by (used in) financing activities | (1,542.8) | 637.9 | (31.7) | (936.6) | |||||||||||||||||||
| Effect of exchange rate changes on cash and cash equivalents of consolidated investment products | — | (2.4) | — | (2.4) | |||||||||||||||||||
| Net change in cash and cash equivalents during year | 583.2 | (14.1) | — | 569.1 | |||||||||||||||||||
| Cash and cash equivalents at beginning of year | 2,066.6 | 77.2 | — | 2,143.8 | |||||||||||||||||||
| Cash and cash equivalents at end of year | $ | 2,649.8 | $ | 63.1 | $ | — | $ | 2,712.9 | |||||||||||||||
| Unaudited Condensed Consolidated Balance Sheet Information | As of | ||||||||||
| (in millions) | 12/31/2024 | 12/31/2023 | |||||||||
| Cash and cash equivalents | $ | 2,649.8 | $ | 2,066.6 | |||||||
| Accounts receivable and accrued revenue | 877.4 | 807.9 | |||||||||
| Investments | 3,000.5 | 2,554.7 | |||||||||
| Assets of consolidated investment products | 2,044.0 | 1,959.3 | |||||||||
| Operating lease assets | 226.8 | 241.1 | |||||||||
| Property, equipment and software, net | 977.0 | 806.6 | |||||||||
| Goodwill and intangible assets | 3,010.9 | 3,150.1 | |||||||||
| Other assets | 685.6 | 692.5 | |||||||||
| Total assets | 13,472.0 | 12,278.8 | |||||||||
| Deferred compensation liabilities | 1,020.7 | 895.0 | |||||||||
Total other liabilities, includes $62.1 at December 31, 2024, and $54.2 at December 31, 2023, from consolidated investment products |
1,001.2 | 1,092.6 | |||||||||
| Non-controlling interests* | 1,104.7 | 786.1 | |||||||||
|
Stockholders' equity attributable to T. Rowe Price Group, Inc., 223.0 common shares outstanding at
December 31, 2024 and 223.9 common shares outstanding at December 31, 2023
|
$ | 10,345.4 | $ | 9,505.1 | |||||||
| Investments in affiliated private investment funds - carried interest | Three months ended | Year ended | |||||||||||||||||||||||||||
| (in millions) | 12/31/2024 | 12/31/2023 | 9/30/2024 | 12/31/2024 | 12/31/2023 | ||||||||||||||||||||||||
| Balance at beginning of period | $ | 499.7 | $ | 578.2 | $ | 497.3 | $ | 519.9 | $ | 467.8 | |||||||||||||||||||
| Capital allocation-based income: | |||||||||||||||||||||||||||||
| Change in accrued carried interest | 12.5 | 51.1 | 35.1 | 134.1 | 223.2 | ||||||||||||||||||||||||
| Acquisition-related amortization and impairments | (17.7) | (10.9) | (30.5) | (87.5) | (61.3) | ||||||||||||||||||||||||
| Net distributions | (67.6) | (98.5) | (2.2) | (139.6) | (109.8) | ||||||||||||||||||||||||
Balance at end of period |
$ | 426.9 | $ | 519.9 | $ | 499.7 | $ | 426.9 | $ | 519.9 | |||||||||||||||||||
| Non-controlling interests (NCI) in consolidated entities | Three months ended | Year ended | |||||||||||||||||||||||||||
| (in millions) | 12/31/2024 | 12/31/2023 | 9/30/2024 | 12/31/2024 | 12/31/2023 | ||||||||||||||||||||||||
| Balance at beginning of period | $ | 203.4 | $ | 221.5 | $ | 205.3 | $ | 192.0 | $ | 190.7 | |||||||||||||||||||
| Capital allocation-based income compensation: | |||||||||||||||||||||||||||||
| Change in accrued carried interest compensation | 3.9 | 15.2 | 11.6 | 42.5 | 70.0 | ||||||||||||||||||||||||
| Acquisition-related amortization and impairments | (7.3) | (4.6) | (13.6) | (37.1) | (25.4) | ||||||||||||||||||||||||
| Net contributions (distributions) | (39.3) | (40.1) | 0.1 | (36.7) | (43.3) | ||||||||||||||||||||||||
Balance at end of period |
$ | 160.7 | $ | 192.0 | $ | 203.4 | $ | 160.7 | $ | 192.0 | |||||||||||||||||||
Three months ended 12/31/2024 |
|||||||||||||||||||||||||||||||||||
| Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) |
Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(6) |
||||||||||||||||||||||||||||||
| U.S. GAAP Basis (FS line item) | $ | 1,256.1 | $ | 568.4 | $ | 4.6 | $ | 156.3 | $ | 439.9 | $ | 1.92 | |||||||||||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
| Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) |
7.3 | 10.4 | — | 2.4 | 8.0 | 0.04 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) |
(14.2) | 14.2 | — | 3.3 | 10.9 | 0.04 | |||||||||||||||||||||||||||||
Contingent consideration(1) |
— | — | — | — | — | — | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) |
(31.4) | 31.4 | — | 7.2 | 24.2 | 0.11 | |||||||||||||||||||||||||||||
| Total acquisition-related | (38.3) | 56.0 | — | 12.9 | 43.1 | 0.19 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) |
6.7 | (6.7) | 9.2 | 0.6 | 1.9 | 0.01 | |||||||||||||||||||||||||||||
Consolidated investment products(3) |
(1.9) | 2.5 | 36.4 | 3.6 | 12.1 | 0.05 | |||||||||||||||||||||||||||||
Other non-operating income(4) |
— | — | (15.9) | (3.7) | (12.2) | (0.05) | |||||||||||||||||||||||||||||
| Adjusted Non-GAAP Basis | $ | 1,222.6 | $ | 620.2 | $ | 34.3 | $ | 169.7 | $ | 484.8 | $ | 2.12 | |||||||||||||||||||||||
Three months ended 12/31/2023 |
|||||||||||||||||||||||||||||||||||
| Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) |
Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(6) |
||||||||||||||||||||||||||||||
| U.S. GAAP Basis (FS line item) | $ | 1,254.8 | $ | 387.2 | $ | 259.7 | $ | 173.3 | $ | 437.6 | $ | 1.90 | |||||||||||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
| Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) |
4.6 | 6.3 | — | 1.7 | 4.6 | 0.02 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) |
(13.5) | 13.5 | — | 3.6 | 9.9 | 0.04 | |||||||||||||||||||||||||||||
Contingent consideration(1) |
9.6 | (9.6) | — | (2.6) | (7.0) | (0.03) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) |
(41.1) | 41.1 | — | 11.1 | 30.0 | 0.14 | |||||||||||||||||||||||||||||
| Total acquisition-related | (40.4) | 51.3 | — | 13.8 | 37.5 | 0.17 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) |
(61.9) | 61.9 | (65.0) | (0.8) | (2.3) | (0.01) | |||||||||||||||||||||||||||||
Consolidated investment products(3) |
(1.8) | 2.3 | (119.2) | (21.8) | (59.1) | (0.26) | |||||||||||||||||||||||||||||
Other non-operating income(4) |
— | — | (26.0) | (7.0) | (19.0) | (0.08) | |||||||||||||||||||||||||||||
| Adjusted Non-GAAP Basis | $ | 1,150.7 | $ | 502.7 | $ | 49.5 | $ | 157.5 | $ | 394.7 | $ | 1.72 | |||||||||||||||||||||||
Three months ended 9/30/2024 |
|||||||||||||||||||||||||||||||||||
| Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) |
Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(6) |
||||||||||||||||||||||||||||||
| U.S. GAAP Basis (FS line item) | $ | 1,172.0 | $ | 613.6 | $ | 212.5 | $ | 185.7 | $ | 603.0 | $ | 2.64 | |||||||||||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
| Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) |
13.6 | 16.9 | — | 2.3 | 14.6 | 0.06 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) |
(4.0) | 4.0 | — | 0.5 | 3.5 | 0.02 | |||||||||||||||||||||||||||||
Contingent consideration(1) |
13.4 | (13.4) | — | (1.8) | (11.6) | (0.05) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) |
(51.5) | 51.5 | — | 7.0 | 44.5 | 0.19 | |||||||||||||||||||||||||||||
| Total acquisition-related | (28.5) | 59.0 | — | 8.0 | 51.0 | 0.22 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) |
(43.4) | 43.4 | (41.1) | 0.3 | 2.0 | 0.01 | |||||||||||||||||||||||||||||
Consolidated investment products(3) |
(1.1) | 2.4 | (85.9) | (6.3) | (39.8) | (0.17) | |||||||||||||||||||||||||||||
Other non-operating income(4) |
— | — | (34.3) | (4.6) | (29.7) | (0.13) | |||||||||||||||||||||||||||||
| Adjusted Non-GAAP Basis | $ | 1,099.0 | $ | 718.4 | $ | 51.2 | $ | 183.1 | $ | 586.5 | $ | 2.57 | |||||||||||||||||||||||
Year ended 12/31/2024 |
|||||||||||||||||||||||||||||||||||
| Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) |
Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(6) |
||||||||||||||||||||||||||||||
| U.S. GAAP Basis (FS line item) | $ | 4,760.3 | $ | 2,333.3 | $ | 486.3 | $ | 683.8 | $ | 2,100.1 | $ | 9.15 | |||||||||||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
| Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) |
37.1 | 50.4 | — | 10.2 | 40.2 | 0.18 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) |
(44.8) | 44.8 | — | 10.4 | 34.4 | 0.15 | |||||||||||||||||||||||||||||
Contingent consideration(1) |
13.4 | (13.4) | — | (1.8) | (11.6) | (0.05) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) |
(156.7) | 156.7 | — | 32.2 | 124.5 | 0.54 | |||||||||||||||||||||||||||||
| Total acquisition-related | (151.0) | 238.5 | — | 51.0 | 187.5 | 0.82 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) |
(104.3) | 104.3 | (96.4) | 1.7 | 6.2 | 0.03 | |||||||||||||||||||||||||||||
Consolidated investment products(3) |
(6.2) | 9.8 | (130.3) | (17.5) | (67.3) | (0.29) | |||||||||||||||||||||||||||||
Other non-operating income(4) |
— | — | (110.9) | (23.9) | (87.0) | (0.38) | |||||||||||||||||||||||||||||
| Adjusted Non-GAAP Basis | $ | 4,498.8 | $ | 2,685.9 | $ | 148.7 | $ | 695.1 | $ | 2,139.5 | $ | 9.33 | |||||||||||||||||||||||
| Year ended 12/31/2023 | |||||||||||||||||||||||||||||||||||
| Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(6) |
Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(7) |
||||||||||||||||||||||||||||||
| U.S. GAAP Basis (FS line item) | $ | 4,474.3 | $ | 1,986.2 | $ | 504.1 | $ | 654.6 | $ | 1,788.7 | $ | 7.76 | |||||||||||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
| Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) |
25.4 | 35.9 | — | 7.9 | 28.0 | 0.12 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) |
(55.0) | 55.0 | — | 10.8 | 44.2 | 0.19 | |||||||||||||||||||||||||||||
Contingent consideration(1) |
82.4 | (82.4) | — | (10.6) | (71.8) | (0.31) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) |
(134.2) | 134.2 | — | 28.8 | 105.4 | 0.46 | |||||||||||||||||||||||||||||
| Total acquisition-related | (81.4) | 142.7 | — | 36.9 | 105.8 | 0.46 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) |
(123.2) | 123.2 | (123.6) | 0.5 | (0.9) | — | |||||||||||||||||||||||||||||
Consolidated investment products(3) |
(9.0) | 11.1 | (164.6) | (22.3) | (84.2) | (0.37) | |||||||||||||||||||||||||||||
Other non-operating income(4) |
— | — | (75.1) | (15.8) | (59.3) | (0.26) | |||||||||||||||||||||||||||||
| Adjusted Non-GAAP Basis | $ | 4,260.7 | $ | 2,263.2 | $ | 140.8 | $ | 653.9 | $ | 1,750.1 | $ | 7.59 | |||||||||||||||||||||||
| Three months ended | Year ended | ||||||||||||||||||||||||||||
| 12/31/2024 | 12/31/2023 | 9/30/2024 | 12/31/2024 | 12/31/2023 | |||||||||||||||||||||||||
| Adjusted net income attributable to T. Rowe Price | $ | 484.8 | $ | 394.7 | $ | 586.5 | $ | 2,139.5 | $ | 1,750.1 | |||||||||||||||||||
| Less: adjusted net income allocated to outstanding restricted stock and stock unit holders | 12.7 | 10.6 | 15.0 | 56.8 | 43.4 | ||||||||||||||||||||||||
| Adjusted net income allocated to common stockholders | $ | 472.1 | $ | 384.1 | $ | 571.5 | $ | 2,082.7 | $ | 1,706.7 | |||||||||||||||||||